|
CHML expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62525548574877E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33226762955019E-15 |
| Normal-vs-Stage2 |
1.71828999999679E-05 |
| Normal-vs-Stage3 |
3.94839999999785E-05 |
| Normal-vs-Stage4 |
7.781200E-04 |
| Stage1-vs-Stage2 |
8.492400E-01 |
| Stage1-vs-Stage3 |
6.200000E-03 |
| Stage1-vs-Stage4 |
4.635900E-04 |
| Stage2-vs-Stage3 |
8.373700E-02 |
| Stage2-vs-Stage4 |
3.074200E-02 |
| Stage3-vs-Stage4 |
4.889400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-16 |
| Normal-vs-AfricanAmerican |
3.682900E-03 |
| Normal-vs-Asian |
1.242990E-01 |
| Caucasian-vs-AfricanAmerican |
2.804000E-01 |
| Caucasian-vs-Asian |
8.584200E-01 |
| AfricanAmerican-vs-Asian |
8.081400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.63344901441087E-13 |
| Normal-vs-Female |
1.92930005304959E-10 |
| Male-vs-Female |
5.596200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.621840E-02 |
| Normal-vs-Age(41-60Yrs) |
2.28472796237611E-12 |
| Normal-vs-Age(61-80Yrs) |
1.19489973471332E-10 |
| Normal-vs-Age(81-100Yrs) |
3.093800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.947800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.249400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.809000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.782370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.484400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.455000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.942700E-03 |
| Normal-vs-Grade 2 |
1.62803104331033E-12 |
| Normal-vs-Grade 3 |
9.71119962223099E-10 |
| Normal-vs-Grade 4 |
4.559600E-02 |
| Grade 1-vs-Grade 2 |
3.875400E-01 |
| Grade 1-vs-Grade 3 |
7.173900E-02 |
| Grade 1-vs-Grade 4 |
5.055400E-03 |
| Grade 2-vs-Grade 3 |
3.085900E-02 |
| Grade 2-vs-Grade 4 |
9.71589999999578E-05 |
| Grade 3-vs-Grade 4 |
2.243500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.85949999997881E-06 |
| ccA subtype-vs-ccB subtype |
3.243800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.12160003507E-09 |
| Normal-vs-N1 |
1.496050E-01 |
| N0-vs-N1 |
6.284800E-01 |
|
|
